Marras, Theodore K <br/><br/>
Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease.  [electronic resource] 

 -  Journal of medical economics  Nov 2019 
 - 1126-1133 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1941-837X 
<br/><br/><label>Standard No.: </label>10.1080/13696998.2019.1620243  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antitubercular Agents--administration & dosage<br/>Comorbidity<br/>Drug Therapy, Combination<br/>Female<br/>Guideline Adherence<br/>Health Expenditures--statistics & numerical data<br/>Health Resources--economics<br/>Health Services--economics<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Insurance Claim Review--statistics & numerical data<br/>Macrolides--administration & dosage<br/>Male<br/>Middle Aged<br/>Mycobacterium Infections, Nontuberculous--drug therapy<br/>Mycobacterium avium Complex<br/>Mycobacterium avium-intracellulare Infection--drug therapy<br/>Practice Guidelines as Topic<br/>Respiratory Tract Infections<br/>Severity of Illness Index<br/>Sex Factors<br/>United States